Comparison of Linagliptin vs Glimepiride on Systemic Hemodynamics in Overweight Patient With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride on Systemic Haemodynamics in Overweight Patient With Type 2 Diabetes: A Secondary Analysis of an 8-Week Randomized Controlled Double-Blind Trial
Diabetes Obes Metab 2020 Jun 01;[EPub Ahead of Print], J Kraaijenhof, MHA Muskiet, L Tonneijck, DM Ouwens, MHH Kramer, DH van Raalte, MM SmitsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.